These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7768000)

  • 1. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template.
    Sestini R; Orlando C; Zentilin L; Lami D; Gelmini S; Pinzani P; Giacca M; Pazzagli M
    Clin Chem; 1995 Jun; 41(6 Pt 1):826-32. PubMed ID: 7768000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction.
    Sestini R; Orlando C; Zentilin L; Gelmini S; Pinzani P; Bianchi S; Selli C; Giacca M; Pazzagli M
    Clin Chem; 1994 Apr; 40(4):630-6. PubMed ID: 7511998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple genetic lesions in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
    Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.
    Hruza C; Dobianer K; Beck A; Czerwenka K; Hanak H; Klein M; Leodolter S; Medl M; Müllauer-Ertl S; Preiser J
    Eur J Cancer; 1993; 29A(11):1593-7. PubMed ID: 8105839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction.
    An HX; Niederacher D; Dominik SI; Kuschel B; Yan H; Dall P; Schnürch HG; Bender HG; Beckmann MW
    Anticancer Res; 1997; 17(4B):3133-6. PubMed ID: 9329619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes.
    Roetger A; Brandt B; Barnekow A
    DNA Cell Biol; 1997 Apr; 16(4):443-8. PubMed ID: 9150431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paradigm for oncogene complementation in human breast cancer.
    Roux-Dosseto M; Martin PM
    Res Virol; 1989; 140(6):571-91. PubMed ID: 2694252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proto-oncogene amplification and human breast tumor phenotype.
    Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
    Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates.
    Diviacco S; Norio P; Zentilin L; Menzo S; Clementi M; Biamonti G; Riva S; Falaschi A; Giacca M
    Gene; 1992 Dec; 122(2):313-20. PubMed ID: 1487146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
    Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
    Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene amplification per se: an independent prognostic factor in human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mol Carcinog; 1994 Dec; 11(4):189-91. PubMed ID: 7999260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
    Friedrichs K; Lohmann D; Höfler H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral heterogeneity for amplified genes in human breast carcinoma.
    Lönn U; Lönn S; Nilsson B; Stenkvist B
    Int J Cancer; 1994 Jul; 58(1):40-5. PubMed ID: 7912234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 oncogene amplification in DNA from human tumours.
    Orlando C; Sestini R; Zentilin L; Gelmini S; Pinzani P; Giacca M; Pazzagli M
    J Biolumin Chemilumin; 1994; 9(3):223-8. PubMed ID: 7942128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors.
    Arai T; Ichimura K; Hirakawa K; Yuasa Y
    Clin Exp Metastasis; 1994 Jul; 12(4):267-75. PubMed ID: 7913669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.
    Berns EM; Klijn JG; van Staveren IL; Portengen H; Noordegraaf E; Foekens JA
    Eur J Cancer; 1992; 28(2-3):697-700. PubMed ID: 1350457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.